Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczyński P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C; EMBODY Investigator Group.
Clowse ME, et al.
Arthritis Rheumatol. 2017 Feb;69(2):362-375. doi: 10.1002/art.39856.
Arthritis Rheumatol. 2017.
PMID: 27598855
Free PMC article.
Clinical Trial.